Harvard stem cell researchers announced a giant leap forward in the quest to find a truly effective treatment for type 1 diabetes, a disease that affects an estimated 3 million Americans.
Read More: http://news.harvard.edu/gazette/story/2014/10/giant-leap-against-diabetes/
Doug Melton (photo 1), Harvard’s Xander University Professor, and his team announced that they have made a tremendous gain on the type 1 diabetes front. “We are now just one preclinical step away from the finish line,” he said. This slide image (photo 2) depicts human stem cell-derived beta cells that have formed islet-like clusters in a mouse. The cells were transplanted to the kidney capsule. This photo was taken two weeks later. The beta cells are making insulin, curing the diabetes in the mouse.